Insulin-Like Growth Factor I Is a Determinant of Hip Bone Mineral Density in Men Less Than 60 years of Age: MINOS Study
Tóm tắt
Several studies show that in elderly men bone mineral density (BMD) is not correlated with the insulin-like growth factor (IGF-I) level, but data are scanty in young men. Results of studies correlating insulin-like growth factor binding protein 3 (IGFBP-3) and BMD in men are discordant. As different hypotheses can explain the discordant results, we evaluated the correlation of BMD with serum IGF-I, IGFBP-3, and IGF-I/IGFBP-3 index in a large cohort of 721 men aged 19–85 years taking into account age, body weight, 17β-estradiol, free testosterone, and parathyroid hormone. Serum IGF-I and IGFBP-3 decreased with age (r = −0.44 and r = −0.36, P = 0.0001). After adjustment for confounding variables, IGF-I correlated weakly positively with BMD and with bone mineral apparent density (BMAD) of hip as well as with cortical thickness of femoral neck, both of which are determined mainly by bone resorption, but not with bone size determined by periosteal apposition. IGF-I correlated weakly positively with BMD at the whole body and at the third lumbar vertebra IGFBP-3 and IGF-I/IGFBP-3 index did not correlate with densitometric parameters. In men aged 19–60 years, IGF-I correlated with BMD and BMAD of total hip and with cortical thickness of femoral neck positively and more strongly than in the entire cohort but not with the size of proximal femur. BMD of total hip was 6% higher in men in the highest quartile of IGF-I than in men in the lowest quartile. IGF-I, IGFBP-3, and IGF-I/IGFBP-3 index did not correlate with densitometric parameters of other sites. In the men aged more than 60 years, neither IGF-I nor IGFBP-3 nor IGF-I/IGFBP-3 index correlated with BMD, BMAD, or bone size. In men aged 19–60 years, the most significant hormonal determinants of BMD and BMAD of the hip and of the cortical thickness of femoral neck were 17β-estradiol and IGF-I (P < 0.05–0.0001). In men aged more than 60 years, the most significant determinants of hip BMD were 17β-estradiol and PTH. In conclusion, IGF-I seems to contribute to the inhibition of bone resorption and to maintaining bone mass of the proximal femur during the phase of slow bone loss in men aged less than 60 years. IGFBP-3 and IGF-I/IGFBP-3 index were not correlated with BMD or bone size.
Tài liệu tham khảo
E Barrett–Connor D Goodman–Gruen (1998) ArticleTitleGender differences in insulin-like growth factor and bone mineral density association in old age: the Rancho Bernardo study. J Bone Miner Res 13 1343–1349
JA Langlois CJ Rosen M Visser MT Hannan T Harris PWF Wilson DP Kiel (1998) ArticleTitleAssociation between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 83 4257–4262
DR Taaffe CS Cooper L Holloway C Duret R Marcus (1999) ArticleTitleLack of association of anabolic hormone status and muscle strength with regional and whole body bone mineral density in healthy men aged 60-79 years. Aging Clin Exp Res 11 4–11 Occurrence Handle1:STN:280:DyaK1M3mvFOgsg%3D%3D
JR Center TV Nguyen PN Sambrook JA Eisman (1999) ArticleTitleHormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab 84 3626–3635 Occurrence Handle1:CAS:528:DyaK1MXms1OhtLY%3D Occurrence Handle10523006
KG O’Connor JD Tobin SM Harman CC Plato TA Roy SS Sherman MR Blackman (1998) ArticleTitle. J Gerontol A Biol Sci Med Sci 53 M176–M182
JAMJL Janssen H Burger RP Stolk DE Grobbee FH de Jong SWJ Lamberts HAP Pols (1998) ArticleTitleGender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and women. Eur J Endocrinol 138 627–632
G Martinez Diaz–Guerra F Hawkins A Rapado MA Ruiz Diaz M Diaz–Curiel (2001) ArticleTitleHormonal and anthropometric predictors of bone mass in healthy elderly men: major effect of sex hormone binding globulin, parathyroid hormone and body weight. Osteoporos Int 12 178–184 Occurrence Handle10.1007/s001980170127 Occurrence Handle1:STN:280:DC%2BD3M3oslKkug%3D%3D Occurrence Handle11315235
J Pfeilschifter C Scheidt–Nave G Leidug–Bruckner HW Woitge WF Blum C Wüster D Haack R Ziegler (1996) ArticleTitleRelationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab 81 2534–2540 Occurrence Handle1:CAS:528:DyaK28XktFaktrk%3D Occurrence Handle8675573
D Rudman PJ Drinka CR Wilson DE Mattson F Scherman MC Cuisinier S Schultz (1994) ArticleTitleRelations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men. Clin Endocrinol 40 653–661 Occurrence Handle1:CAS:528:DyaK2cXkslCisb4%3D
AG Johansson A Forslund L Hambraeus WF Blum S Ljunghall (1994) ArticleTitleGrowth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. J Bone Miner Res 9 915–921
P Gillberg H Olofsson H Mallmin WF Blum S Ljunghall AG Nilsson (2002) ArticleTitleBone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF-I) and IGF-binding protein (IGFBP)-3 in Swedish men. Calcif Tissue Int 70 22–29 Occurrence Handle10.1007/s002230020048 Occurrence Handle1:CAS:528:DC%2BD38XjvFSjtbY%3D Occurrence Handle11907704
G Ravaglia P Forti F Maioli B Nesi L Pratelli D Cucinotta L Bastagli G Cavalli (2000) ArticleTitleSerum levels of insulin-like growth factor-I are related to age and not to body composition in healthy men and women. Gerontol A Biol Sci Med Sci 55 M516–M521
S Ormarsdottir Ö Ljunggren H Malmin H Olofsson WF Blum L Lööf (2001) ArticleTitleCirculating levels of insulin-like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density. Liver 21 123–129 Occurrence Handle10.1034/j.1600-0676.2001.021002123.x Occurrence Handle1:STN:280:DC%2BD3MzjsVGrtw%3D%3D Occurrence Handle11318981
JOL Jorgensen N Vahl TB Hansen C Skjaerbaek S Fisker H Orskov C Hagen JS Christiansen (1998) ArticleTitleDeterminants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects. Clin Endocrinol 48 479–486
S Rajaram DJ Baylink S Mohan (1997) ArticleTitleInsulin-like growth factor-binding proteins in serum and other biological fluids: regulation and function. Endocrine Rev 18 801–831
JAMJL Janssen RP Stolk HAP Pols DE Grobbee FH de Jong SWJ Lamberts (1998) ArticleTitleSerum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels. Clin Endocrin 48 471–478
CA Benbassat KC Maki TG Unterman (1997) ArticleTitleCirculating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, a,d dehydroepiandrosterone sulfate levels and anthropometric measures. . 82 1484–1491 Occurrence Handle1:CAS:528:DyaK2sXjtVGmu7o%3D
G Paolisso S Ammendola A del Buono A Gambardella M Riondino MR Tagliamonte MR Rizzo C Carella M Varricchio (1997) ArticleTitleSerum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. J Clin Endocrinol Metab 82 2204–2209 Occurrence Handle9215295
AG Johansson EF Eriksen E Lindh B Langdahl WF Blum A Lindahl Ö Ljunggren S Ljunghall (1997) ArticleTitleReduced serum levels of the growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men. J Clin Endocrinol Metab 82 2795–2798 Occurrence Handle1:CAS:528:DyaK2sXlvFems7s%3D Occurrence Handle9284698
P Szulc F Marchand F Dubeouf PD Delmas (2000) ArticleTitleCross-sectional assessment of age-related bone loss in men: the MINOS study. Bone 26 123–129 Occurrence Handle10.1016/S8756-3282(99)00255-0 Occurrence Handle1:STN:280:DC%2BD3c7ktFyktg%3D%3D Occurrence Handle10678406
DR Carter ML Bouxsein R Marcus (1992) ArticleTitleNew approaches for interpreting projected bone densitometry data. J Bone Miner Res 7 137–145 Occurrence Handle1:STN:280:By2B3sfjs1Q%3D Occurrence Handle1570758
R Martin D Burr (1984) ArticleTitleNon-invasive measurement of long bone cross-sectional moment of inertia by photon absorptiometry. J Biomech 17 195–201 Occurrence Handle1:STN:280:BiuB3sboslM%3D
T Beck AC Looker CB Ruff H Sievanen HW Wahner (2000) ArticleTitleStructural trends in the aging femoral neck and proximal shaft: analysis of Third National Health and Nutrtion Examination Survey dual-energy X-ray absorptiometry data. J Bone Miner Res 15 2297–2304 Occurrence Handle1:STN:280:DC%2BD3M%2FpsF2mtA%3D%3D Occurrence Handle11127194
P Rey E Sornay–Rendu P Garnero B Vey–Marty PD Delmas (1994) ArticleTitleMeasurement of feorearm bone mineral density by X-ray absorptiometry: comparison with other skeletal sites. Rev Rhum Engl Ed 61 548–554
G Boivin PJ Meunier (2002) ArticleTitleThe degree of mineralization of bone tissue measured by computerized quantitative contact microradiography. Calcif Tissue Int 70 503–511 Occurrence Handle10.1007/s00223-001-2048-0 Occurrence Handle1:CAS:528:DC%2BD38XlvV2ktLo%3D Occurrence Handle12019458
PW Lu CT Cowell SA Lloyd–Jones JN Briody R Howman–Giles (1996) ArticleTitleVolumetric bone mineral density in normal subjects aged 5–27 years. J Clin Endocrinol Metab 81 1586–1590 Occurrence Handle1:CAS:528:DyaK28Xit1OntrY%3D Occurrence Handle8636372
PG Chatelais JJ van Wyk KC Copeland SL Blethen LE Underwood (1983) ArticleTitleEffect of in vitro action of serum preoteases or exposure to acid on measurable immunoreactive somatomedin-C in serum. J Clin Endocrinol Metab 56 376–383 Occurrence Handle6337177
G Sassolas P Chatelain R Cohen JP Boissel S Laporte J Galleyrand B Claustrat A Elmcharfi JA Cayvialle H Cohen S Ferry L Underwood (1984) ArticleTitleEffects of human pancreatic tumor growth hormone-releasing (hpGRH1-44-NH2) on immunoreactive and bioactive plasma growth hormone in normal young men. J Clin Endocrinol Metab 59 705–709 Occurrence Handle1:CAS:528:DyaL2cXlvVCmsr4%3D Occurrence Handle6148353
A Juul P Dalgaard WF Blum P Bang K Hall KF Michaelsen J Müller NE Skakkebaek (1995) ArticleTitleSerum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 80 2534–2542 Occurrence Handle1:CAS:528:DyaK2MXnsVCjtbk%3D Occurrence Handle7543116
G Paolisso S Ammendola A del Buono A Gambardella M Riondino MR Tagliamonte MR Rizzo C Carella M Varricchio (1997) ArticleTitleSerum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. J Clin Endocrinol Metab 82 2204–2209 Occurrence Handle9215295
AG Bremond B Claustrat RC Rudigoz P Seffert J Corniau (1982) ArticleTitleEstradiol, androstenedione, and dehydroepiandrosterone sulfate in the ovarian and peripheral blood of postmenopausal patients with and without endometrial cancer. Gynecol Oncol 14 119–124 Occurrence Handle1:STN:280:Bi2B3sjhvVw%3D Occurrence Handle6212296
MC Chapuy P Preziosi M Maamer S Arnaud P Galan S Hercberg PJ Meunier (1997) ArticleTitlePrevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7 439–443 Occurrence Handle10.1007/s001980050030 Occurrence Handle1:STN:280:DyaK1c%2Fos1Kgug%3D%3D Occurrence Handle9425501
E Arvat L Gianotti S Grottoli BP Imbimbo V Lenaerts R Deghenghi F Camanni E Ghigo (1994) ArticleTitleArginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. J Clin Endocrinol Metab 79 1440–1443 Occurrence Handle1:CAS:528:DyaK2MXit1ektrk%3D Occurrence Handle7962341
E Ghigo S Goffi M Nicolosi E Arvat F Valente E Mazza MC Ghigo F Camanni (1990) ArticleTitleGrowth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. J Clin Endocrinol Metab 71 1481–1485 Occurrence Handle1:CAS:528:DyaK3MXkt1amu78%3D Occurrence Handle2229304
M Russell–Aulet CA Jaffe R Demott–Friberg AL Barkan (1999) ArticleTitleIn vivo semiquantification of hypothalamic growth hormone-releasing hormone (GHRH) output in humans: evidence for relative GHRH deficiency in aging. J Clin Endocrinol Metab 84 3490–3497 Occurrence Handle1:CAS:528:DyaK1MXms1Ohtrk%3D Occurrence Handle10522985
J Alba–Roth OA Müller J Schopohl K von Werder (1988) ArticleTitleArginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinoi Metab 67 1186–1189 Occurrence Handle1:CAS:528:DyaL1MXmvFKitw%3D%3D
M Russell–Aulet B Shapiro CA Jaffe MD Gross AL Barkan (1998) ArticleTitlePeak bone mass in young healthy men is correlated with the magnitude of endogenous growth hormone secretion. J Clin Endocrinol Metab 83 3463–3468
T Rosen L Wilhelmsen K Landin–Wilhelmsen G Lappas BA Bengtsson (1997) ArticleTitleIncreased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 137 240–245 Occurrence Handle1:CAS:528:DyaK2sXntVyksLs%3D Occurrence Handle9330587
C Wuster R Abs BA Bengtsson H Bennmarker U Feldt–Rasmussen E Hernberg–Stahl JP Monson B Westberg P Wilton (2001) ArticleTitleThe influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 16 398–405 Occurrence Handle1:CAS:528:DC%2BD3MXptlyjtg%3D%3D Occurrence Handle11204440
G Johansson T Rosén I Bosaeus L Sjöström BA Bengtsson (1996) ArticleTitleTwo years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 81 2865–2873 Occurrence Handle8768843
BY Reed JE Zerwekh K Sakhaee NA Breslau F Gottschalk CYC Pak (1995) ArticleTitleSerum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res 10 1218–1224
MJ Välimäki PI Salmela J Salmi J Viikari M Kataja H Turunen E Soppi (1999) ArticleTitleEffects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults. Eur J Endocrinol 140 545–554
SJ Holmes RW Whitehouse R Swindell G Economou JE Adams SM Shalet (1995) ArticleTitleEffect of growth hormone replacement on bone mass in adults onset growth hormone deficiency. Clin Endocrinol 42 627–633 Occurrence Handle1:STN:280:ByqA287hvVI%3D
JC ter Maaten H de Boer O Kamp L Stuurman EA van der Veen (1999) ArticleTitleLong-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency. J Clin Endocrinol Metab 84 2373–2380 Occurrence Handle1:CAS:528:DyaK1MXks1agtb0%3D Occurrence Handle10404806
BMK Biller G Sesmilo HBA Baum D Hayden D Schoenfeld A Klibanski (2000) ArticleTitleWithdrawal of long-term physiological growth hormone (GH) administration: differential effects on bon density and body composition in men with adult-onset GH deficiency. J Clin Endocrinol Metab 85 970–976 Occurrence Handle1:CAS:528:DC%2BD3cXisFOrtbg%3D Occurrence Handle10720025
K Landin–Wilhelmsen A Nilsson I Bosaeus BA Bengtsson (2003) ArticleTitleGrowth hormone increases bone mineral content in postmenopausal osteoporosis: a randomized placebo-controlled trial. J Bone Miner Res 18 393–405 Occurrence Handle12619921
CJ Rosen C Wüster (2003) ArticleTitleGrowth hormone rising: did we quit too quickly? J Bone Miner Res 18 406–409
N Bravenboer P Holzman H de Boer JC Roos EA van der Veen P Lips (1997) ArticleTitleThe effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient men. J Clin Endocrinol Metab 82 1818–1822 Occurrence Handle1:CAS:528:DyaK2sXjs1akt7Y%3D Occurrence Handle9177389
AA Toogood JE Adams PA O’Neill SM Shalet (1997) ArticleTitleElderly patients with adult-onset growth hormone deficiency are not osteopenic. J Clin Endocrinol Metab 82 1462–1466 Occurrence Handle1:CAS:528:DyaK2sXjtVGmurc%3D Occurrence Handle9141534
D Rudman AG Feller HS Nagraj GA Gergans PY Lalitha AF Goldberg RA Schlenker L Cohn IW Rudman DE Mattson (1990) ArticleTitleEffects of human growth hormone in men over 60 years old. N Engl J Med 323 1–6 Occurrence Handle1:CAS:528:DyaK3MXisVSru78%3D Occurrence Handle2355952
MA Papadakis D Grady D Black MJ Tierney GAW Gooding M Schambelan C Grunfeld (1996) ArticleTitleGrowth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 124 708–716 Occurrence Handle1:CAS:528:DyaK28XislOisrw%3D Occurrence Handle8633830
R Fernholm M Bramnert E Hägg A Hilding DJ Baylink S Mohan M Thorén (2000) ArticleTitleGrowth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. J Clin Endocrinol Metab 85 4104–4112 Occurrence Handle1:CAS:528:DC%2BD3cXotlWnur4%3D Occurrence Handle11095440
C Christmas KG O’Connor SM Harman JD Tobin T Münzer MF Ballantoni CS Clair KM Pabst JD Sorkin MR Blackman (2002) ArticleTitleGrowth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men. J Gerontol A Biol Sci Med Sci 57A M12–M18 Occurrence Handle1:CAS:528:DC%2BD38XnvFenug%3D%3D
D Thiébaud P Burckhardt M Costanza D Sloutskis D Gilliard F Quinodoz AF Jacquet B Burnand (1997) ArticleTitleImportance of albumin, 25(OH)-vitamin D and IGFBP-3 as risk factors in elderly women and men with hip fracture. Osteoporos Int 7 457–462 Occurrence Handle10.1007/s001980050033 Occurrence Handle9425504
M Ernst GA Rodan (1990) ArticleTitleIncreased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 127 807–814 Occurrence Handle1:CAS:528:DyaK3cXlt1Kkur8%3D Occurrence Handle2164921
WF Blum K Albertsson–Wikland S Rosberg MB Ranke (1993) ArticleTitleSerum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 76 1610–1616 Occurrence Handle1:CAS:528:DyaK3sXltV2gtbc%3D Occurrence Handle7684744